4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine, 90.0%, 5g

3-Chloro-5,5-dimethyl-4,5-dihydroisoxazole, 97%, 250mg

2-(2-OXO-2-(4-METHOXYPHENYL)ETHYL)MALONONITRILE, 95.0%, 5g

Sodium 3-Bromopropanesulfonate>98.0%(T)25g

Boc-Asp(OMe), 95.0%, 10g

5-methyl-2-(methylsulfanyl)-3,4-dihydropyrimidin-4-one, 95%, 250mg

Pyrogallol, min 98%, pour synthèse, 100 g, conditionnement verre

2-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)ethano-hydrazide, 2g

2-Fluoro-5-(methylthio)benzoic acid, 97%, 5g

2-Amino-3-(methylamino)pyrazine, 95.0%, 10g

Tert-butyl3-hydroxy-3-[2-(trifluoromethyl)phenyl]azetidine-1-carboxylate, 98%, 100mg

((1R,5S)-3-Oxabicyclo[3.1.0]hexan-1-yl)methanol, 98%, 500mg

6-Bromoimidazo[1,2-a]pyrimidine-2-carboxylic acid, 97%, 250mg